Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

BCTX

BriaCell Therapeutics Corp

Apr 23 • 04:00PM ET

2.32

Dollar change +0.12
Percentage change 5.45	%

Healthcare • Biotechnology • Canada • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.67	Insider Own	12.15%	Shs Outstand	15.98M	Perf Week	1.75%
Market Cap	37.07M	Forward P/E	-	EPS next Y	-1.40	Insider Trans	0.00%	Shs Float	14.04M	Perf Month	-7.94%
Income	-12.61M	PEG	-	EPS next Q	-0.55	Inst Own	15.45%	Short Float	4.83%	Perf Quarter	-42.29%
Sales	0.00M	P/S	-	EPS this Y	-6.92%	Inst Trans	-	Short Ratio	8.00	Perf Half Y	-54.86%
Book/sh	-0.51	P/B	-	EPS next Y	-0.72%	ROA	-54.35%	Short Interest	0.68M	Perf Year	-68.44%
Cash/sh	0.39	P/C	5.94	EPS next 5Y	-	ROE	-202.12%	52W Range	2.01 - 7.59	Perf YTD	-60.34%
Dividend Est.	-	P/FCF	-	EPS past 5Y	32.71%	ROI	-	52W High	-69.43%	Beta	1.12
Dividend TTM	-	Quick Ratio	2.99	Sales past 5Y	0.00%	Gross Margin	-	52W Low	15.42%	ATR (14)	0.24
Dividend Ex-Date	-	Current Ratio	2.99	EPS Y/Y TTM	7.72%	Oper. Margin	0.00%	RSI (14)	41.23	Volatility	10.19% 9.84%
Employees	12	Debt/Eq	-	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	18.00
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	7.71%	Payout	-	Rel Volume	0.41	Prev Close	2.20
Sales Surprise	-	EPS Surprise	-255.00%	Sales Q/Q	-	Earnings	Mar 19 BMO	Avg Volume	84.78K	Price	2.32
SMA20	-10.25%	SMA50	-21.04%	SMA200	-51.57%	Trades		Volume	36,120	Change	5.45%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-14-22	Initiated	H.C. Wainwright	Buy	$25

Today 08:00AM	BriaCell Announces Oral and Poster Presentations at ASCO 2024 (GlobeNewswire)
Apr-10-24 08:00AM	BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+ and Bria-PROS+ Clinical Candidates for Breast and Prostate Cancer (GlobeNewswire)
Apr-09-24 08:00AM	BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR (GlobeNewswire)
Mar-19-24 06:52AM	BCTX Stock Earnings: BriaCell Therapeutics Reported Results for Q2 2024 (InvestorPlace) -6.55%
Mar-07-24 08:00AM	BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies (GlobeNewswire) -7.05%
08:00AM	Loading…
Mar-06-24 08:00AM	BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference (GlobeNewswire) -8.24%
Feb-27-24 08:00AM	BriaCell Provides Update on Alleged Illegal Trading of Public Securities (GlobeNewswire)
Feb-07-24 08:00AM	BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case (GlobeNewswire)
Feb-06-24 08:30AM	Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing (GlobeNewswire) +5.34%
Jan-30-24 10:48PM	BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting (GlobeNewswire)
Jan-04-24 08:45AM	BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with Eye-Bulging Metastatic Breast Cancer (GlobeNewswire) +6.60%
Dec-28-23 08:55AM	BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients (GlobeNewswire)
Dec-20-23 08:40AM	BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset (GlobeNewswire)
Dec-06-23 09:31AM	BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS (GlobeNewswire)
09:00AM	BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical Benefit (GlobeNewswire)
07:00AM	Loading…
Nov-30-23 07:00AM	BriaCell Records New Responder with Remarkable Improvement of Eye-Bulging Metastatic Tumor (GlobeNewswire)
Nov-03-23 08:31AM	BriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS IND (GlobeNewswire) +9.41%
Nov-01-23 10:49AM	BCTX: Year in Review (Zacks) -7.53%
Oct-25-23 09:15AM	BriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology Candidate (GlobeNewswire)
Oct-20-23 09:15AM	October is Breast Cancer Awareness Month BriaCell is Leading the Fight with its Innovative Technology (GlobeNewswire) -5.51%
Oct-18-23 09:00AM	BriaCell Announces Presentations at the 2023 Society for the Immunotherapy of Cancer (SITC) and San Antonio Breast Cancer (SABC) Conferences (GlobeNewswire) -5.26%
Oct-11-23 09:10AM	BriaCell To Host Virtual Key Opinion Leader Event on Bria-IMT Potential in Advanced Metastatic Breast Cancer on October 26, 2023 Featuring Dr. Adam M. Brufsky from University of Pittsburgh School of Medicine and Dr. Saranya Chumsri from Mayo Clinic (GlobeNewswire)
Oct-04-23 09:00AM	BriaCell Partners with New York Cancer & Blood Specialists (NYCBS) for Pivotal Phase 3 Study of Bria-IMT in Advanced Breast Cancer (GlobeNewswire)
Oct-03-23 09:00AM	BriaCell Initiates Pivotal Phase 3 Study of Bria-IMT in Advanced Metastatic Breast Cancer (GlobeNewswire)
Sep-08-23 07:00AM	BriaCell Reports Benchmark-Beating Patient Survival and Clinical Benefit in Advanced Metastatic Breast Cancer (GlobeNewswire)
Aug-31-23 11:54AM	BriaCell Therapeutics Corp. Announces Closing of Plan of Arrangement Spinning Out BriaPro Therapeutics Corp. to Existing Shareholders (GlobeNewswire)
08:21AM	BriaCell Accepts Letter of Intent from Weill Cornell Medicine Outlining Plans to Initiate a Clinical Trial of Bria-IMT in High-Risk Early-Stage Triple Negative Breast Cancer (GlobeNewswire)
Aug-25-23 02:33PM	BriaCell Receives Court Approval for the Share Arrangement Spinning Out BriaPro Therapeutics (SpinCo) to Existing Shareholders (GlobeNewswire)
Aug-18-23 12:21PM	BriaCell Therapeutics Corp. Announces Voting Results From Special Meeting (GlobeNewswire)
Aug-16-23 08:36AM	BriaCell Awarded National Cancer Institute Grant to Advance its Bria-OTS Immunotherapy for Cancer (GlobeNewswire)
07:00AM	Loading…
Jul-10-23 07:00AM	BCTX: Pivotal Study Protocol Cleared (Zacks)
Jun-27-23 08:05AM	FDA Approves BriaCells Pivotal Registrational Study Design in Advanced Metastatic Breast Cancer (GlobeNewswire) -7.99%
May-25-23 09:00AM	BriaCell Enters Definitive Arrangement Agreement for the Spin Out of BriaPro Therapeutics Corp. (GlobeNewswire)
May-19-23 11:38AM	BriaCell Closes $4 Million Strategic Investment by Prevail Partners, LLC at US$8.63 per Share (GlobeNewswire) +5.59%
May-15-23 08:00AM	BriaCell Announces $4 Million Strategic Investment and Clinical Alliance with Prevail Partners, LLC and Prevail InfoWorks, Inc. (GlobeNewswire)
Apr-27-23 05:33AM	BCTX: Posters Galore at AACR (Zacks Small Cap Research)
Apr-17-23 07:45AM	BriaCell Presents Positive Data Demonstrating Survival and Clinical Benefits in Advanced Metastatic Breast Cancer at the 2023 AACR (GlobeNewswire) +5.28%
Apr-10-23 07:29AM	BriaCell Therapeutics (TSE:BCT) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Mar-30-23 08:45AM	BriaCell Announces Intention to Spin-Out Certain Pre-Clinical Assets into a Newly Created SpinCo Entity whereby Shareholders to Receive One New Share of SpinCo in Addition to Each Current Share of BriaCell Already Held (GlobeNewswire)
Mar-15-23 09:15AM	BriaCell to Present Clinical and Survival Data in Advanced Metastatic Breast Cancer at the 2023 AACR Annual Meeting (GlobeNewswire)
Mar-14-23 06:27AM	A BriaCell Therapeutics Corp. (TSE:BCT) insider increased their holdings by 20% last year (Simply Wall St.)
Mar-09-23 04:56AM	BCTX: 82% Survival Benefit (Zacks Small Cap Research) -10.14%
Feb-23-23 08:00AM	BriaCell Reports Positive Survival Data in Advanced Metastatic Breast Cancer (GlobeNewswire)
Feb-11-23 07:13AM	BriaCell Therapeutics Corp. (TSE:BCT) most popular amongst individual investors who own 59%, insiders hold 14% (Simply Wall St.)
Feb-09-23 11:09PM	BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting (GlobeNewswire)
Jan-24-23 09:07AM	BriaCell CEO Letter to Shareholders (GlobeNewswire)
Jan-23-23 12:06PM	BriaCell to investigate alleged illegal trading activity by outsiders (American City Business Journals) +5.68%
08:41AM	BriaCell to Investigate Alleged Illegal Trading of Public Securities (GlobeNewswire)
Jan-20-23 12:15PM	Lab Notes: Amicus founder gets national honor; Capstan and Code Bio land on list of companies to watch (American City Business Journals)
Jan-18-23 08:47AM	BriaCell Announces Positive End of Phase II Meeting with the FDA for Bria-IMT Combination in Advanced Metastatic Breast Cancer (GlobeNewswire) -7.06%
Jan-10-23 09:00AM	BriaCell Announces New Patent Issuance, Bria-OTS IND Timing Guidance, and Additional Clinical Sites to Boost Enrolment (GlobeNewswire) +9.62%
Dec-19-22 06:16AM	BCTX: Down in San Antone (Zacks Small Cap Research) -5.39%
Dec-08-22 09:25AM	BriaCell Announces Positive Clinical and Quality of Life Data in Advanced Metastatic Breast Cancer at 2022 San Antonio Breast Cancer Symposium® (GlobeNewswire)
Dec-02-22 10:00AM	BriaCells Lead Candidate Bria-IMT Shows Promising Results For Advanced Breast Cancer Patients (News Direct)
Nov-30-22 08:04AM	IPAs Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement to Discover and Develop Anti-Cancer Antibodies (Business Wire)
Nov-21-22 05:10AM	BCTX: SITC Poster Presentation (Zacks Small Cap Research)
Nov-15-22 08:00AM	BriaCell CEO Discusses Positive Clinical Results of its Breast Cancer Immunotherapy Treatment in an Audio Interview with SmallCapVoice.com (GlobeNewswire)
Nov-10-22 09:00AM	BriaCell Reports Positive Breast Cancer Efficacy Data with Bria-IMT Immunotherapy Treatment at SITC Annual Meeting (GlobeNewswire) +5.39%
Oct-31-22 07:54AM	BCTX: Fiscal Year 2022 Results (Zacks Small Cap Research)
Oct-21-22 09:00AM	BriaCell Announces Successful Completion of Phase I Portion of Clinical Study in Advanced Breast Cancer; Randomized Phase II Efficacy Evaluation Progressing (GlobeNewswire)
Oct-14-22 07:13AM	Here's Why We're Not Too Worried About BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation (Simply Wall St.)
Oct-12-22 09:00AM	BriaCell Announces New Clinical Trial Site to Bring Novel Cancer Treatments to Advanced Breast Cancer Patients (GlobeNewswire) +5.70%
Sep-28-22 09:15AM	BriaCell to Present New Clinical Data at the 2022 San Antonio Breast Cancer Symposium® December 6th and 7th (GlobeNewswire)
Sep-14-22 09:20AM	BriaCell Partners with Caris Life Sciences® to Expand Patient Outreach and Molecular Profiling (GlobeNewswire)
Sep-07-22 09:25AM	BriaCell Announces Presentation at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting (GlobeNewswire)
Aug-17-22 10:13AM	What Type Of Shareholders Own The Most Number of BriaCell Therapeutics Corp. (TSE:BCT) Shares? (Simply Wall St.)
Aug-05-22 02:41PM	BriaCell signs exclusive licensing deal with UMBC for cancer treatment candidate (American City Business Journals)
Aug-04-22 09:00AM	BriaCell Secures License for a Promising Novel Anti-Cancer Agent (GlobeNewswire)
Jul-21-22 08:23AM	BriaCell Therapeutics Corp. (TSE:BCT) insider upped their holding earlier this year (Simply Wall St.)
Jul-05-22 09:00AM	BriaCell Partners with Waisman Biomanufacturing to Manufacture and Supply Prostate Cancer Immunotherapy (GlobeNewswire)
Jun-29-22 09:00AM	BriaCell Enters Research Agreement to Identify Novel Targets for Cancer Treatment (GlobeNewswire)
Jun-24-22 09:00AM	BriaCell Anti-Cancer Technology Published in Leading Cancer Drug Discovery Journal (GlobeNewswire) +11.05%
Jun-23-22 07:40AM	BCTX: New Sites Expand Bria-IMT Trial (Zacks Small Cap Research)
May-18-22 09:15AM	BriaCell Adds Additional Clinical Sites to Broaden Patient Access and Further Boost Enrollment (GlobeNewswire) -7.10%
May-06-22 03:02PM	We're Hopeful That BriaCell Therapeutics (TSE:BCT) Will Use Its Cash Wisely (Simply Wall St.) -6.01%
Apr-13-22 08:00AM	BriaCell Receives FDA Fast Track Approval for Targeted Breast Cancer Immunotherapy (GlobeNewswire) -8.88%
Apr-12-22 04:30PM	BriaCell Presents Development Details of Bria-OTS Platform Technology at the American Association for Cancer Research (AACR) Annual Meeting 2022 (GlobeNewswire) -15.15%
Apr-07-22 08:30AM	BriaCell advances preparatory work for new Bria-OTS breast cancer clinical trial (GlobeNewswire)
Mar-29-22 05:44AM	BCTX: Second Quarter Results (Zacks Small Cap Research)
Feb-28-22 08:00AM	BriaCell Adds Two Clinical Trial Sites to Accelerate Patient Enrollment (GlobeNewswire)
Feb-23-22 08:00AM	BriaCell Appoints Leading Immunologist Dr. Alexander Kharazi to its Scientific Advisory Board (GlobeNewswire)
Feb-16-22 08:00AM	BriaCell Appoints Renowned Oncologist, Giuseppe Del Priore, MD, MPH, as Chief Medical Officer (GlobeNewswire)
Feb-11-22 04:12AM	Bullish BriaCell Therapeutics Corp. (TSE:BCT) insiders were rewarded last week as their US$12m investment inflated to US$17m (Simply Wall St.)
Feb-10-22 11:00AM	BriaCell Virtually Opens the Market (PR Newswire)
08:00AM	BriaCell to Present at the AACR 2022; Provides Corporate Buyback and Insider Buying Update (GlobeNewswire)
Jan-19-22 04:57PM	BriaCell Therapeutics Corp. Announces Results of 2022 Annual and Special Meeting of Shareholders (GlobeNewswire)
Jan-11-22 09:00AM	TMX Group Equity Financing Statistics - December 2021 (PR Newswire)
Jan-05-22 05:15AM	BCTX: Game, Set and Match: HLAs Score Success (Zacks Small Cap Research)
Dec-29-21 08:48PM	BriaCell to Uplist and Trade on the Toronto Stock Exchange from TSX Venture Exchange under 'BCT'; Remains 'BCTX' on Nasdaq (GlobeNewswire)
Dec-16-21 08:00AM	BriaCell Announces Insiders Intention to Purchase up to 10% of Public Market Securities (GlobeNewswire)
Dec-09-21 09:00AM	BriaCell Summarizes Clinical Data Poster Presented at the 2021 San Antonio Breast Cancer Symposium® (GlobeNewswire) -5.24%
Nov-18-21 09:00AM	BriaCell Adds Mary Crowley Cancer Research Center as a Clinical Trial Site for its Phase I/IIa Breast Cancer Study (GlobeNewswire)
Nov-12-21 09:00AM	BriaCell Announces Update on Previously Announced Securities Buyback Program and Participation at Upcoming Conferences (GlobeNewswire)
Nov-08-21 05:59AM	BCTX: Enhancing the Checkpoint Revolution with Bria-IMT (Zacks Small Cap Research)
Nov-05-21 09:00AM	BriaCell Adds Pioneering Immunologist and Cancer Immunotherapy Expert, Suzanne Ostrand-Rosenberg, Ph.D., to its Scientific Advisory Board (GlobeNewswire)
Nov-02-21 09:00AM	BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of Directors (GlobeNewswire) +9.45%
Oct-22-21 06:00AM	Here's What BriaCell Therapeutics Corp.'s (CVE:BCT) Shareholder Ownership Structure Looks Like (Simply Wall St.)
Oct-05-21 09:00AM	October is Breast Cancer Awareness Month BriaCell is Advancing the Fight with its Immunotherapy (GlobeNewswire)
Sep-23-21 08:00AM	BriaCell Therapeutics CEO Emphasizes Recent Key Developments in Audio Interview with SmallCapVoice.com (GlobeNewswire)
Sep-22-21 09:00AM	BriaCell Announces TSXV Acceptance of Normal Course Issuer Bid (GlobeNewswire) +6.92%

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company, which engages in the development of immunotherapies for the treatment of cancer. Its technologies include Bria-IMT and Bria-OTS. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BCTX

BriaCell Therapeutics Corp

Upgrade your FINVIZ experience